MicroRNAs e células-tronco mesenquimais: Esperança para a hipertensão pulmonar

14Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Pulmonary hypertension is a devastating and refractory disease and there is no cure for this disease. Recently, microRNAs and mesenchymal stem cells emerged as novel methods to treat pulmonary hypertension. More than 20 kinds of microRNAs may participate in the process of pulmonary hypertension. It seems microRNAs or mesenchymal stem cells can ameliorate some symptoms of pulmonary hypertension in animals and even improve heart and lung function during pulmonary hypertension. Nevertheless, the relationship between mesenchymal stem cells, microRNAs and pulmonary hypertension is not clear. And the mechanisms underlying their function still need to be investigated. In this study we review the recent findings in mesenchymal stem cells - and microRNAs-based pulmonary hypertension treatment, focusing on the potential role of microRNAs regulated mesenchymal stem cells in pulmonary hypertension and the role of exosomes between mesenchymal stem cells and pulmonary hypertension.

Cite

CITATION STYLE

APA

Zhu, Z., Fang, Z., Hu, X., & Zhou, S. (2015, July 1). MicroRNAs e células-tronco mesenquimais: Esperança para a hipertensão pulmonar. Brazilian Journal of Cardiovascular Surgery. Sociedade Brasileira de Cirurgia Cardiovascular. https://doi.org/10.5935/1678-9741.20150033

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free